Northern Trust’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.1M Buy
527,966
+23,128
+5% +$1.04M ﹤0.01% 1531
2025
Q4
$16M Sell
504,838
-20,204
-4% -$630K ﹤0.01% 1814
2025
Q3
$14.8M Sell
525,042
-4,071
-0.8% -$123K ﹤0.01% 1886
2025
Q2
$19.5M Sell
529,113
-87,751
-14% -$3.03M ﹤0.01% 1667
2025
Q1
$24.2M Sell
616,864
-10,785
-2% -$486K ﹤0.01% 1515
2024
Q4
$29.2M Buy
627,649
+51,926
+9% +$2.35M ﹤0.01% 1462
2024
Q3
$26M Buy
575,723
+17,037
+3% +$811K ﹤0.01% 1461
2024
Q2
$27.5M Sell
558,686
-14,567
-3% -$594K ﹤0.01% 1357
2024
Q1
$19.7M Sell
573,253
-12,567
-2% -$454K ﹤0.01% 1606
2023
Q4
$21.6M Buy
585,820
+31,564
+6% +$730K ﹤0.01% 1563
2023
Q3
$11.2M Buy
554,256
+5,472
+1% +$120K ﹤0.01% 1916
2023
Q2
$11.2M Buy
548,784
+27,780
+5% +$416K ﹤0.01% 1977
2023
Q1
$7.86M Buy
521,004
+9,968
+2% +$220K ﹤0.01% 2182
2022
Q4
$12.2M Sell
511,036
-2,585
-0.5% -$75K ﹤0.01% 1870
2022
Q3
$18.1M Sell
513,621
-4,743
-0.9% -$201K ﹤0.01% 1559
2022
Q2
$18.1M Buy
518,364
+5,462
+1% +$193K ﹤0.01% 1600
2022
Q1
$25.3M Buy
512,902
+45,866
+10% +$2.54M ﹤0.01% 1511
2021
Q4
$36.1M Sell
467,036
-8,019
-2% -$823K 0.01% 1349
2021
Q3
$50.8M Sell
475,055
-30,062
-6% -$3.44M 0.01% 1062
2021
Q2
$67.3M Sell
505,117
-10,499
-2% -$1.22M 0.01% 902
2021
Q1
$63.9M Buy
515,616
+85,750
+20% +$13M 0.01% 930
2020
Q4
$60.7M Sell
429,866
-6,465
-1% -$717K 0.01% 927
2020
Q3
$33.1M Buy
436,331
+25,441
+6% +$1.58M 0.01% 1221
2020
Q2
$18.6M Buy
410,890
+70,479
+21% +$2.53M ﹤0.01% 1682
2020
Q1
$10.4M Buy
340,411
+55,019
+19% +$1.48M ﹤0.01% 1849
2019
Q4
$5.99M Buy
285,392
+1,451
+0.5% +$34K ﹤0.01% 2482
2019
Q3
$6.78M Buy
283,941
+154,071
+119% +$4.48M ﹤0.01% 2378
2019
Q2
$3.77M Buy
129,870
+55,285
+74% +$1.46M ﹤0.01% 2709
2019
Q1
$1.73M Buy
74,585
+5,049
+7% +$114K ﹤0.01% 3165
2018
Q4
$1.6M Buy
+69,536
New +$1.54M ﹤0.01% 3164

Other funds holding TWST

Northern Trust's TWST Position: Q1 2026 in Review

Northern Trust increased its Twist Bioscience (TWST) stake by 4.6% in Q1 2026, buying an estimated $1.04M and bringing the position to 527,966 shares worth $25.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1531.

Northern Trust first reported a position in TWST in Q4 2018 and has held it in 30 quarters since. The position peaked at $67.3M in Q2 2021. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Northern Trust held 527,966 shares of Twist Bioscience worth $25.1M as of Q1 2026.
  • Northern Trust bought 23,128 Twist Bioscience shares in Q1 2026, an estimated $1.04M.
  • Twist Bioscience made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1531 holding.
  • Northern Trust first reported a position in Twist Bioscience in Q4 2018 and has held it in 30 quarters since.
  • Northern Trust's Twist Bioscience position peaked at $67.3M in Q2 2021.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.